Related Experiment Videos
Clinical orthotopic cardiac transplantation
American Journal of Surgery
|June 1, 1987
Summary
Orthotopic cardiac transplantation survival rates have significantly improved, reaching 80% at 1 year and 60% at 5 years. Despite challenges like donor shortages and immunosuppression complications, it
Area of Science:
- Cardiology
- Transplant Surgery
- Immunology
Background:
- Orthotopic cardiac transplantation outcomes have dramatically improved since the late 1960s.
- The introduction of cyclosporine has been a key factor in enhancing patient survival rates.
Purpose of the Study:
- To review the current status and outcomes of orthotopic cardiac transplantation.
- To highlight the advancements and persistent challenges in cardiac transplant procedures.
Main Methods:
- Review of clinical data and survival statistics.
- Analysis of complications associated with immunosuppressive therapy.
- Assessment of patient functional rehabilitation and quality of life post-transplant.
Main Results:
- One and five-year survival rates are now 80% and 60%, respectively.
- Donor availability remains the primary limiting factor for cardiac transplantation.
- Significant complications persist due to immunosuppressive therapy, and costs remain high.
- Most patients achieve good functional rehabilitation and are symptom-free.
Conclusions:
- Orthotopic cardiac transplantation is now an established therapeutic option for end-stage heart disease.
- Continued research is needed to address donor shortages and mitigate immunosuppression-related complications.